LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models
2012 · Investigational New Drugs · 161 citations
https://doi.org/10.1007/s10637-012-9912-9